An interventional study of AI-Based Voice Emotion Detection-Guided Counselling and Usual Care (Control) in Adult Congenital Heart Disease, Symptom Clusters and Frailty, sponsored by Mackay Memorial Hospital. Not yet recruiting. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.
Sponsored by Mackay Memorial Hospital · Not applicable, Interventional, and Treatment
The goal of this three-year mixed-methods observational study with an embedded randomized controlled trial is to develop and validate a frailty risk prediction model and evaluate an artificial intelligence-based voice emotion detection-guided counselling intervention in adults with congenital heart disease (ACHD).
The main questions it aims to answer are:
Are symptom clusters associated with frailty and psychological outcomes in adults with congenital heart disease?
Can symptom clusters and psychosocial factors be used to predict frailty risk over time in ACHD patients?
Does an AI-based voice emotion detection-guided counselling intervention improve psychological outcomes, fatigue, and quality of life among high-risk ACHD patients?
Researchers will compare ACHD patients receiving AI-based voice emotion detection-guided counselling with those receiving usual care to determine whether the intervention reduces depression, anxiety, sleep disturbance, fatigue, and frailty risk, and improves grit and quality of life.
Participants will:
Complete longitudinal assessments of symptom clusters, frailty, and psychological status at baseline and follow-up time points
Participate in qualitative interviews to explore lived experiences related to symptoms and frailty
Receive AI-based voice emotion detection-guided counselling (intervention group only in Year 3)
991 studies on the registry are indexed under Heart Defects, Congenital; 251 are open to participants now.
This study's planned enrollment of 410 is above the median of 60 across 507 interventional studies indexed under Heart Defects, Congenital.
Browse Heart Defects, Congenital studies →Mackay Memorial Hospital is the lead sponsor of 118 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants assigned to this arm will receive an artificial intelligence-based voice emotion detection-guided counselling intervention in addition to usual care. The intervention uses voice emotion analysis to provide personalized psychological feedback and counselling aimed at improving emotional regulation, reducing psychological distress, and enhancing quality of life.
Behavioral: AI-Based Voice Emotion Detection-Guided Counselling
Participants assigned to this arm will receive usual clinical care for adult congenital heart disease without the AI-based voice emotion detection-guided counselling intervention.
Behavioral: Usual Care (Control)
Participants assigned to the intervention arm will receive an artificial intelligence-based voice emotion detection-guided counselling intervention in addition to usual care. The intervention uses voice recordings collected during structured counselling sessions to analyze emotional features, including emotional valence and arousal, through artificial intelligence-based voice emotion detection algorithms. Based on the analyzed emotional profiles, individualized psychological feedback and counselling guidance are provided to support emotional regulation, stress coping, and adaptive self-management. The counselling content is tailored to participants' emotional states and symptom experiences and focuses on reducing psychological distress, improving sleep and fatigue management, enhancing grit, and promoting quality of life. The intervention is delivered by trained healthcare professionals following a standardized protocol, with sessions conducted at predefined intervals during the inter
Usual Care
Depression and Anxiety assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form Scales
The PROMIS Depression Short Form evaluates negative mood, feelings of hopelessness, helplessness, and loss of interest. The PROMIS Anxiety Short Form assesses emotional distress related to feelings of fear, worry, tension, and hyperarousal. Each scale consists of multiple items rated on a 5-point Likert scale (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often, 5 = Almost Always) based on the participant's experiences during the past 7 days. Raw scores are summed and converted to PROMIS T-scores, standardized to a population mean of 50 with a standard deviation of 10. Possible raw score range: 8-40 (for the 8-item short form). Higher scores indicate greater levels of depressive or anxiety symptoms (worse outcomes).
Time frame: Baseline, 2 weeks, 1 month, and 3 months after initiation of the intervention
Chinese version of the Satisfaction with Life Scale; SWLS
This study used the Chinese version of the Satisfaction With Life Scale (SWLS) (Wu \& Yao, 2006), which consists of five items rated on a seven-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). Higher total scores indicate greater overall life satisfaction. The scale has been applied in adult patients with congenital heart disease (Liu, Lu, et al., 2024) and demonstrated excellent internal consistency, with a Cronbach's α of 0.93, indicating good reliability of the Chinese version.
Time frame: Baseline, 2 weeks, 1 month, and 3 months after initiation of the intervention
Grit-10
Duckworth et al. (2007) proposed the Grit Scale to conceptualize grit as comprising two dimensions: Perseverance of Effort (six items) and Consistency of Interests (six items), yielding a total of 12 items. The overall internal consistency of the original scale was 0.85, with Cronbach's α values of 0.78 for the Perseverance of Effort subscale and 0.84 for the Consistency of Interests subscale, indicating good reliability (Duckworth \& Quinn, 2009). The Chinese version of the Grit Scale (Grit-10) was adapted from the original 12-item English version and revised to include 10 items loading on two factors. The Passion factor (reverse-coded) includes items such as "I often set a goal but then quickly change it," whereas the Perseverance factor includes items such as "I finish whatever I begin." Responses are rated on a five-point Likert scale ranging from 1 (not at all like me) to 5 (very much like me). Each item is scored from 1 to 5; odd-numbered items are reverse-coded and even-numbere
Time frame: Baseline, 2 weeks, 1 month, and 3 months after initiation of the intervention
The Chinese Version of Fatigue Assessment Scale; FAS-C
The Fatigue Assessment Scale-Chinese version (FAS-C) is a self-reported instrument designed to measure subjective fatigue and is particularly suitable for use in populations with chronic illnesses, cardiovascular diseases, and the general adult population (Michielsen et al., 2003). The original FAS consists of 10 items encompassing two domains: physical fatigue and mental fatigue. The Chinese version was developed through a rigorous process of translation, back-translation, and cultural adaptation, and has demonstrated satisfactory psychometric properties, including excellent internal consistency (Cronbach's α = 0.92) and good test-retest reliability (Lee, 2024). Each item is rated on a five-point Likert scale ranging from 1 (never) to 5 (always), yielding a total score between 10 and 50, with higher scores indicating greater fatigue severity. The FAS-C is brief and easy to administer, with high sensitivity in distinguishing different levels of fatigue, making it suitable for clinica
Time frame: Baseline, 2 weeks, 1 month, and 3 months after initiation of the intervention
No study locations are listed for this record.
Start is estimated for Mar 2026; primary completion for Dec 2028, 33 months later.
Of 205 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 33 months is close to that.
Counting every sponsor, half of 223 studies reached it within 34 months; a quarter within 17 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.